Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05%
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The main purpose of this trial is to demonstrate the predictive value of the clinical
diagnosis of clearance of Actinic Keratoses after treatment with Ingenol Mebutate using
histopathological examination as the standard.